Early Access — free while we kick the tires
EdgarHawk

Wurth Douglas Clark

Director

Director

Latest: Director buying · March 2026

1 filing analyzed · 1 company · Latest 2026-05-18

Never miss a filing from Wurth Douglas Clark

Watch this insider and we'll alert you the moment they file — at any company.

Companies

Company Buys Sells Direction
Bluejay Diagnostics, Inc. BJDX 1 0 Net buying

Activity

May 2026
low
Buy
12,500 shares
$25,000
Significance 3/10

Director Wurth Douglas Clark purchases 12,500 shares of BJDX at $2.00 in private placement as stock trades near 52-week lows.

Director Wurth Douglas Clark acquired 12,500 shares at $2.00 per share through a private placement structure on 2026-03-14, expanding his holdings from 108 to 12,608 shares. However, the FLAG designation indicates this transaction is a non-discretionary PIPE or registered direct offering allocation, not an open-market purchase driven by insider conviction. The current stock price of $1.72 is -89.7% from the 52-week high of $16.68, and the company is fundamentally distressed: revenue stands at $249,040.00 with net income of $-1,919,241.00 and market cap of only $1,779,709.80. The 30-day price decline of -14.0% and 90-day decline of -36.1% reflect deteriorating market sentiment. Because this is a structured private placement rather than a discretionary buy decision, the transaction should not be interpreted as insider conviction that value has emerged at depressed levels.

Related insiders